Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Person › Details

Titus Kaletta (Numares AG)

Kaletta, Titus (Numares 201607– Executive Board Member COO before Consulting + Galantos Pharma + Devgen)

 

Organisations Organisation Numares AG
  Group Numares (Group)
  Former/major organisation Dr. Titus Kaletta Innovation Consulting
Products Product NMR spectroscopy
  Product 2 LIFE SCIENCES
     

Numares AG. (8/10/16). "Press Release: Numares AG Appoints Dr. Titus Kaletta as Executive Board Member". Regensburg.

The supervisory board of numares AG has appointed Dr. Titus Kaletta (47) as a member of the executive board effective July 1, 2016. His main responsibility will be to further develop sales throughout Europe and Asia.

Kaletta holds a doctoral degree in biochemistry and worked for various international life science companies in different managerial positions, before joining numares in the spring of 2016. His previous positions focused on R&D and strategic business development.

“In Titus Kaletta, we have acquired a highly dedicated manager who possesses several years of experience in the life science industry. Thanks to his scientific and economic expertise, he will provide us with decisive support for the further expansion of our sales activities. Titus Kaletta's new position is an expression of our uninterrupted growth rate and we are currently creating the structures required for this development. At the beginning of the year, we entered a partnership with Limbach, the leading laboratory group in Germany, to conduct lipoprotein tests. This represents an important step for tapping into new markets,” explains Dr. Volker Pfahlert, CEO of numares AG.

"I am very excited about my new role. numares has great potential to gain additional customers for its innovative and cost-effective technology. Furthermore, numares test systems have proven to be reliable, resilient and reproducible and have already been incorporated into various application areas as part of the daily clinical routine. This has formed a solid basis, which we will now use to approach others involved in the fields of diagnostics, clinical research and science throughout Europe and Asia," explains Dr. Titus Kaletta, executive board member of numares AG.


Media contact

numares AG
Dipl.-Biol. Christiane Proll, MBA
Tel.: +49 941 2809 49-14
E-Mail: christiane.proll(at)numares.com

IRA WÜLFING KOMMUNIKATION GmbH
Dr. Reinhard Saller
Tel.: +49 89 2000 30-38
E-Mail: reinhard.saller(at)wuelfing-kommunikation.de

   
Record changed: 2018-02-20

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px


More documents for Titus Kaletta


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top